Market Tracker

12/22 9:53am ET

Theravance Inc (NASDAQ:THRX)

14.99
Real-Time Quote
 -0.23 / -1.51%
Today’s Change
12.56
Today|||52-Week Range
32.88
-47.80%
Year-to-Date

Today’s Trading

Previous close15.22
Today’s open15.06
Day’s range14.76 - 15.46
Volume2,003,568
Average volume (3 months)1,088,021
Market cap$1.8B
Dividend yield6.73%
Data as of 9:37am ET, 12/22/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+29.17%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book5.67

Competitors

 Today’s
change
Today’s
% change
AUXLAuxilium Pharmaceuti...-0.07-0.20%
MDCOMedicines Co-0.02-0.07%
ACORAcorda Therapeutics ...+0.44+1.10%
NBIXNeurocrine Bioscienc...-0.28-1.14%
Data as of 9:53am ET, 12/22/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts